A potential setback in the personalized medicine of cancer

20:00 EDT 16 Apr 2018 | AAAS

(Centro Nacional de Investigaciones Oncológicas (CNIO)) One of the most constant and exhaustive searches in cancer research is for a treatment aimed specifically at the Ras family of genes, the most common oncogenes and those that initiate many of the most lethal tumors. However, the results of this hypothetical treatment may be far less positive than speculated due to a manuscript published by the Genomic Instability Group at the Spanish National Cancer Research Centre (CNIO).

Original Article: A potential setback in the personalized medicine of cancer

More From BioPortfolio on "A potential setback in the personalized medicine of cancer"